Template:Acute cystitis antibiotics - Revision history

Danbot: Add pediatric outpatient and inpatient UTI dosing

2026-03-20T12:58:56Z

Add pediatric outpatient and inpatient UTI dosing

← Older revision		Revision as of 12:58, 20 March 2026
Line 30:		Line 30:
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Imipenem/Cilastatin\|dose=500mg IV q8hr\|context=Inpatient}}		*{{AntibioticDose\|disease=Acute cystitis\|drug=Imipenem/Cilastatin\|dose=500mg IV q8hr\|context=Inpatient}}
	*{{AntibioticDose\|drug=Cefotetan\|dose=500 mg IM/IV q12h\|context=UTI, uncomplicated\|disease=Acute cystitis\|population=Adult}}		*{{AntibioticDose\|drug=Cefotetan\|dose=500 mg IM/IV q12h\|context=UTI, uncomplicated\|disease=Acute cystitis\|population=Adult}}

			===Pediatric===
			*{{AntibioticDose\|disease=Acute cystitis\|drug=Trimethoprim-Sulfamethoxazole DS\|display=TMP/SMX\|dose=6-12mg/kg/day (TMP) PO divided BID x 7-10 days\|context=Pediatric\|population=Pediatric}}
			*{{AntibioticDose\|disease=Acute cystitis\|drug=Cephalexin\|dose=25-50mg/kg/day PO divided q6-8h x 7-10 days (max 500mg/dose)\|context=Pediatric\|population=Pediatric}}
			*{{AntibioticDose\|disease=Acute cystitis\|drug=Nitrofurantoin\|dose=5-7mg/kg/day PO divided q6h x 7-10 days; avoid in infants <1 month\|context=Pediatric\|population=Pediatric}}
			*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefpodoxime\|dose=10mg/kg/day PO divided BID (max 200mg/dose)\|context=Pediatric\|population=Pediatric}}
			*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefixime\|dose=8mg/kg/day PO daily (max 400mg)\|context=Pediatric\|population=Pediatric}}

			====Pediatric Inpatient====
			*{{AntibioticDose\|disease=Acute cystitis\|drug=Ceftriaxone\|dose=50-75mg/kg IV daily (max 2g)\|context=Pediatric Inpatient\|population=Pediatric}}
			*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefotaxime\|dose=50mg/kg IV q8hrs (max 2g/dose)\|context=Pediatric Inpatient\|population=Pediatric}}
			*{{AntibioticDose\|disease=Acute cystitis\|drug=Gentamicin\|dose=2.5mg/kg IV q8hrs\|context=Pediatric Inpatient\|population=Pediatric}} +/- [[Ampicillin]] 50mg/kg IV q6hrs

Danbot: Add Cefotetan AntibioticDose entry

2026-03-20T10:51:41Z

Add Cefotetan AntibioticDose entry

← Older revision		Revision as of 10:51, 20 March 2026
Line 29:		Line 29:
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefepime\|dose=2gm IV q8hr\|context=Inpatient}}, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefepime\|dose=2gm IV q8hr\|context=Inpatient}}, OR
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Imipenem/Cilastatin\|dose=500mg IV q8hr\|context=Inpatient}}		*{{AntibioticDose\|disease=Acute cystitis\|drug=Imipenem/Cilastatin\|dose=500mg IV q8hr\|context=Inpatient}}
			*{{AntibioticDose\|drug=Cefotetan\|dose=500 mg IM/IV q12h\|context=UTI, uncomplicated\|disease=Acute cystitis\|population=Adult}}

Danbot: Strip translate tags to enable SMW subobject creation

2026-03-20T02:53:39Z

Strip translate tags to enable SMW subobject creation

← Older revision		Revision as of 02:53, 20 March 2026
Line 1:		Line 1:
	~~<noinclude><languages/></noinclude>~~		===Outpatient=== '''Women, Uncomplicated'''
	~~<translate>~~

	===Outpatient=== ~~<!--T:1-->~~

	~~<!--T:2-->~~
	'''Women, Uncomplicated'''
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Nitrofurantoin\|dose=ER 100mg BID x 5d\|context=Outpatient, Women Uncomplicated}}, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Nitrofurantoin\|dose=ER 100mg BID x 5d\|context=Outpatient, Women Uncomplicated}}, OR
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Trimethoprim-Sulfamethoxazole DS\|display=TMP/SMX\|dose=DS (160/800mg) 1 tab BID x 3d (Females) x7days (Males)\|context=Outpatient, Women Uncomplicated}}, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Trimethoprim-Sulfamethoxazole DS\|display=TMP/SMX\|dose=DS (160/800mg) 1 tab BID x 3d (Females) x7days (Males)\|context=Outpatient, Women Uncomplicated}}, OR
Line 18:		Line 12:
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefpodoxime\|dose=200 mg BID x10-14d\|context=Outpatient, Women Complicated}}		*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefpodoxime\|dose=200 mg BID x10-14d\|context=Outpatient, Women Complicated}}

	~~<!--T:3-->~~		'''Women, Concern for [[Urethritis\|Urethritis]]'''
	'''Women, Concern for [[~~Special:MyLanguage/~~Urethritis\|Urethritis]]'''
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Ceftriaxone\|dose=250mg IM x1\|context=Urethritis Concern}} AND [[azithromycin]] 1gm PO x1 AND [[nitrofurantoin]] ER 100mg BID x5d, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Ceftriaxone\|dose=250mg IM x1\|context=Urethritis Concern}} AND [[azithromycin]] 1gm PO x1 AND [[nitrofurantoin]] ER 100mg BID x5d, OR
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Levofloxacin\|dose=500mg QD x 14d\|context=Urethritis Concern}} (covers urinary pathogens, [[~~Special:MyLanguage/~~GC\|GC]], and [[~~Special:MyLanguage/~~chlamydia\|chlamydia]])		*{{AntibioticDose\|disease=Acute cystitis\|drug=Levofloxacin\|dose=500mg QD x 14d\|context=Urethritis Concern}} (covers urinary pathogens, [[GC\|GC]], and [[chlamydia\|chlamydia]])
	**[[~~Special:MyLanguage/~~GC\|GC]] resistance to fluoroquinolones is increasing		**[[GC\|GC]] resistance to fluoroquinolones is increasing

	~~<!--T:4-->~~
	'''Men'''		'''Men'''
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Ciprofloxacin\|dose=500mg BID x10-14d\|context=Men}}, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Ciprofloxacin\|dose=500mg BID x10-14d\|context=Men}}, OR
Line 30:		Line 22:


	===Inpatient Options=== ~~<!--T:5-->~~		===Inpatient Options=== *{{AntibioticDose\|disease=Acute cystitis\|drug=Ciprofloxacin\|dose=400mg IV q12hr\|context=Inpatient}}, OR

	~~<!--T:6-->~~
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Ciprofloxacin\|dose=400mg IV q12hr\|context=Inpatient}}, OR
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Ceftriaxone\|dose=1gm IV QD\|context=Inpatient}}, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Ceftriaxone\|dose=1gm IV QD\|context=Inpatient}}, OR
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefotaxime\|dose=1-2gm IV q8hr\|context=Inpatient}}, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefotaxime\|dose=1-2gm IV q8hr\|context=Inpatient}}, OR
Line 40:		Line 29:
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefepime\|dose=2gm IV q8hr\|context=Inpatient}}, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefepime\|dose=2gm IV q8hr\|context=Inpatient}}, OR
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Imipenem/Cilastatin\|dose=500mg IV q8hr\|context=Inpatient}}		*{{AntibioticDose\|disease=Acute cystitis\|drug=Imipenem/Cilastatin\|dose=500mg IV q8hr\|context=Inpatient}}
	~~</translate>~~

Danbot: Convert to AntibioticDose with disease=Acute cystitis

2026-03-19T23:38:23Z

Convert to AntibioticDose with disease=Acute cystitis

← Older revision		Revision as of 23:38, 19 March 2026
Line 6:		Line 6:
	<!--T:2-->		<!--T:2-->
	'''Women, Uncomplicated'''		'''Women, Uncomplicated'''
	*~~[[Special:MyLanguage/~~Nitrofurantoin\|~~Nitrofurantoin]]~~ ER 100mg BID x 5d, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Nitrofurantoin\|dose=ER 100mg BID x 5d\|context=Outpatient, Women Uncomplicated}}, OR
	*~~[[Special:MyLanguage/~~TMP/SMX\|~~TMP/SMX]]~~ DS (160/800mg) 1 tab BID x 3d (Females) x7days (Males), OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Trimethoprim-Sulfamethoxazole DS\|display=TMP/SMX\|dose=DS (160/800mg) 1 tab BID x 3d (Females) x7days (Males)\|context=Outpatient, Women Uncomplicated}}, OR
	*~~[[Special:MyLanguage/~~Cephalexin\|~~Cephalexin]]~~ 250mg QID x 5d, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Cephalexin\|dose=250mg QID x 5d\|context=Outpatient, Women Uncomplicated}}, OR
	*~~[[Special:MyLanguage/~~Ciprofloxacin\|~~Ciprofloxacin]]~~ 250mg BID x3d		*{{AntibioticDose\|disease=Acute cystitis\|drug=Ciprofloxacin\|dose=250mg BID x3d\|context=Outpatient, Women Uncomplicated}}
	**Avoid using fluoroquinolone for the first-line treatment of uncomplicated urinary tract infections (UTIs) in women.<ref>Choosing Wisely. American Urogynecologic Society. http://www.choosingwisely.org/societies/american-urogynecologic-society</ref>		**Avoid using fluoroquinolone for the first-line treatment of uncomplicated urinary tract infections (UTIs) in women.<ref>Choosing Wisely. American Urogynecologic Society. http://www.choosingwisely.org/societies/american-urogynecologic-society</ref>
	*~~[[Special:MyLanguage/~~Fosfomycin\|~~Fosfomycin]]~~ 3 g PO once		*{{AntibioticDose\|disease=Acute cystitis\|drug=Fosfomycin\|dose=3 g PO once\|context=Outpatient, Women Uncomplicated}}
	**Lower clinical and microbiologic success compared to nitrofurantoin TID for 5 days <ref>Huttner, A., Kowalczyk, A., Turjeman, A., Babich, T., Brossier, C., Eliakim-Raz, N., … Harbarth, S. (2018). Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial. JAMA: The Journal of the American Medical Association, 319(17), 1781–1789.</ref>		**Lower clinical and microbiologic success compared to nitrofurantoin TID for 5 days <ref>Huttner, A., Kowalczyk, A., Turjeman, A., Babich, T., Brossier, C., Eliakim-Raz, N., … Harbarth, S. (2018). Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial. JAMA: The Journal of the American Medical Association, 319(17), 1781–1789.</ref>

	'''Women, Complicated'''		'''Women, Complicated'''
	*~~[[Special:MyLanguage/~~Ciprofloxacin\|~~Ciprofloxacin]]~~ 500mg BID x10-14d, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Ciprofloxacin\|dose=500mg BID x10-14d\|context=Outpatient, Women Complicated}}, OR
	*~~[[Special:MyLanguage/~~Cefpodoxime\|~~Cefpodoxime]]~~ 200 mg BID x10-14d		*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefpodoxime\|dose=200 mg BID x10-14d\|context=Outpatient, Women Complicated}}

	<!--T:3-->		<!--T:3-->
	'''Women, Concern for [[Special:MyLanguage/Urethritis\|Urethritis]]'''		'''Women, Concern for [[Special:MyLanguage/Urethritis\|Urethritis]]'''
	*~~[[Special:MyLanguage/~~Ceftriaxone\|~~Ceftriaxone]]~~ 250mg IM x1 AND [[~~Special:MyLanguage/azithromycin\|~~azithromycin]] 1gm PO x1 AND [[~~Special:MyLanguage/nitrofurantoin\|~~nitrofurantoin]] ER 100mg BID x5d, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Ceftriaxone\|dose=250mg IM x1\|context=Urethritis Concern}} AND [[azithromycin]] 1gm PO x1 AND [[nitrofurantoin]] ER 100mg BID x5d, OR
	*~~[[Special:MyLanguage/~~Levofloxacin\|~~Levofloxacin]]~~ 500mg QD x 14d (covers urinary pathogens, [[Special:MyLanguage/GC\|GC]], and [[Special:MyLanguage/chlamydia\|chlamydia]])		*{{AntibioticDose\|disease=Acute cystitis\|drug=Levofloxacin\|dose=500mg QD x 14d\|context=Urethritis Concern}} (covers urinary pathogens, [[Special:MyLanguage/GC\|GC]], and [[Special:MyLanguage/chlamydia\|chlamydia]])
	**[[Special:MyLanguage/GC\|GC]] resistance to fluoroquinolones is increasing		**[[Special:MyLanguage/GC\|GC]] resistance to fluoroquinolones is increasing

	<!--T:4-->		<!--T:4-->
	'''Men'''		'''Men'''
	*~~[[Special:MyLanguage/~~Ciprofloxacin\|~~Ciprofloxacin]]~~ 500mg BID x10-14d, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Ciprofloxacin\|dose=500mg BID x10-14d\|context=Men}}, OR
	*~~[[Special:MyLanguage/~~Cefpodoxime\|~~Cefpodoxime]]~~ 200 mg BID x10-14d		*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefpodoxime\|dose=200 mg BID x10-14d\|context=Men}}


Line 33:		Line 33:

	<!--T:6-->		<!--T:6-->
	*~~[[Special:MyLanguage/~~Ciprofloxacin\|~~Ciprofloxacin]]~~ 400mg IV q12hr, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Ciprofloxacin\|dose=400mg IV q12hr\|context=Inpatient}}, OR
	*~~[[Special:MyLanguage/~~Ceftriaxone\|~~Ceftriaxone]]~~ 1gm IV QD, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Ceftriaxone\|dose=1gm IV QD\|context=Inpatient}}, OR
	*~~[[Special:MyLanguage/~~Cefotaxime\|~~Cefotaxime]]~~ 1-2gm IV q8hr, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefotaxime\|dose=1-2gm IV q8hr\|context=Inpatient}}, OR
	*~~[[Special:MyLanguage/~~Gentamicin\|~~Gentamicin]]~~ 3mg/kg/day divided q8hr +/- ampicillin 1–2 gm q4hr, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Gentamicin\|dose=3mg/kg/day divided q8hr\|context=Inpatient}} +/- ampicillin 1–2 gm q4hr, OR
	*~~[[Special:MyLanguage/~~Piperacillin/Tazobactam\|~~Piperacillin/Tazobactam]]~~ 3.375 gm IV q6hr, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Piperacillin/Tazobactam\|dose=3.375 gm IV q6hr\|context=Inpatient}}, OR
	*~~[[Special:MyLanguage/~~Cefepime\|~~Cefepime]]~~ 2gm IV q8hr, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefepime\|dose=2gm IV q8hr\|context=Inpatient}}, OR
	*~~[[Special:MyLanguage~~/~~Imipenem~~\|~~Imipenem]]~~ 500mg IV q8hr		*{{AntibioticDose\|disease=Acute cystitis\|drug=Imipenem/Cilastatin\|dose=500mg IV q8hr\|context=Inpatient}}
	</translate>		</translate>

Ostermayer: Marked this version for translation

2026-01-20T06:04:28Z

Marked this version for translation

← Older revision		Revision as of 06:04, 20 January 2026
Line 2:		Line 2:
	<translate>		<translate>

	===Outpatient===		===Outpatient=== <!--T:1-->

			<!--T:2-->
	'''Women, Uncomplicated'''		'''Women, Uncomplicated'''
	*[[Special:MyLanguage/Nitrofurantoin\|Nitrofurantoin]] ER 100mg BID x 5d, OR		*[[Special:MyLanguage/Nitrofurantoin\|Nitrofurantoin]] ER 100mg BID x 5d, OR
Line 17:		Line 18:
	*[[Special:MyLanguage/Cefpodoxime\|Cefpodoxime]] 200 mg BID x10-14d		*[[Special:MyLanguage/Cefpodoxime\|Cefpodoxime]] 200 mg BID x10-14d

			<!--T:3-->
	'''Women, Concern for [[Special:MyLanguage/Urethritis\|Urethritis]]'''		'''Women, Concern for [[Special:MyLanguage/Urethritis\|Urethritis]]'''
	*[[Special:MyLanguage/Ceftriaxone\|Ceftriaxone]] 250mg IM x1 AND [[Special:MyLanguage/azithromycin\|azithromycin]] 1gm PO x1 AND [[Special:MyLanguage/nitrofurantoin\|nitrofurantoin]] ER 100mg BID x5d, OR		*[[Special:MyLanguage/Ceftriaxone\|Ceftriaxone]] 250mg IM x1 AND [[Special:MyLanguage/azithromycin\|azithromycin]] 1gm PO x1 AND [[Special:MyLanguage/nitrofurantoin\|nitrofurantoin]] ER 100mg BID x5d, OR
Line 22:		Line 24:
	**[[Special:MyLanguage/GC\|GC]] resistance to fluoroquinolones is increasing		**[[Special:MyLanguage/GC\|GC]] resistance to fluoroquinolones is increasing

			<!--T:4-->
	'''Men'''		'''Men'''
	*[[Special:MyLanguage/Ciprofloxacin\|Ciprofloxacin]] 500mg BID x10-14d, OR		*[[Special:MyLanguage/Ciprofloxacin\|Ciprofloxacin]] 500mg BID x10-14d, OR
Line 27:		Line 30:


	===Inpatient Options===		===Inpatient Options=== <!--T:5-->

			<!--T:6-->
	*[[Special:MyLanguage/Ciprofloxacin\|Ciprofloxacin]] 400mg IV q12hr, OR		*[[Special:MyLanguage/Ciprofloxacin\|Ciprofloxacin]] 400mg IV q12hr, OR
	*[[Special:MyLanguage/Ceftriaxone\|Ceftriaxone]] 1gm IV QD, OR		*[[Special:MyLanguage/Ceftriaxone\|Ceftriaxone]] 1gm IV QD, OR

Ostermayer at 06:03, 20 January 2026

2026-01-20T06:03:53Z

← Older revision		Revision as of 06:03, 20 January 2026
Line 1:		Line 1:
	<languages/>		<noinclude><languages/></noinclude>
	<translate>		<translate>

Ostermayer: Prepared the page for translation

2026-01-20T06:03:28Z

Prepared the page for translation

← Older revision		Revision as of 06:03, 20 January 2026
Line 1:		Line 1:
			<languages/>
			<translate>

	===Outpatient===		===Outpatient===

	'''Women, Uncomplicated'''		'''Women, Uncomplicated'''
	*[[Nitrofurantoin]] ER 100mg BID x 5d, OR		*[[Special:MyLanguage/Nitrofurantoin\|Nitrofurantoin]] ER 100mg BID x 5d, OR
	*[[TMP/SMX]] DS (160/800mg) 1 tab BID x 3d (Females) x7days (Males), OR		*[[Special:MyLanguage/TMP/SMX\|TMP/SMX]] DS (160/800mg) 1 tab BID x 3d (Females) x7days (Males), OR
	*[[Cephalexin]] 250mg QID x 5d, OR		*[[Special:MyLanguage/Cephalexin\|Cephalexin]] 250mg QID x 5d, OR
	*[[Ciprofloxacin]] 250mg BID x3d		*[[Special:MyLanguage/Ciprofloxacin\|Ciprofloxacin]] 250mg BID x3d
	**Avoid using fluoroquinolone for the first-line treatment of uncomplicated urinary tract infections (UTIs) in women.<ref>Choosing Wisely. American Urogynecologic Society. http://www.choosingwisely.org/societies/american-urogynecologic-society</ref>		**Avoid using fluoroquinolone for the first-line treatment of uncomplicated urinary tract infections (UTIs) in women.<ref>Choosing Wisely. American Urogynecologic Society. http://www.choosingwisely.org/societies/american-urogynecologic-society</ref>
	*[[Fosfomycin]] 3 g PO once		*[[Special:MyLanguage/Fosfomycin\|Fosfomycin]] 3 g PO once
	**Lower clinical and microbiologic success compared to nitrofurantoin TID for 5 days <ref>Huttner, A., Kowalczyk, A., Turjeman, A., Babich, T., Brossier, C., Eliakim-Raz, N., … Harbarth, S. (2018). Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial. JAMA: The Journal of the American Medical Association, 319(17), 1781–1789.</ref>		**Lower clinical and microbiologic success compared to nitrofurantoin TID for 5 days <ref>Huttner, A., Kowalczyk, A., Turjeman, A., Babich, T., Brossier, C., Eliakim-Raz, N., … Harbarth, S. (2018). Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial. JAMA: The Journal of the American Medical Association, 319(17), 1781–1789.</ref>

	'''Women, Complicated'''		'''Women, Complicated'''
	*[[Ciprofloxacin]] 500mg BID x10-14d, OR		*[[Special:MyLanguage/Ciprofloxacin\|Ciprofloxacin]] 500mg BID x10-14d, OR
	*[[Cefpodoxime]] 200 mg BID x10-14d		*[[Special:MyLanguage/Cefpodoxime\|Cefpodoxime]] 200 mg BID x10-14d

	'''Women, Concern for [[Urethritis]]'''		'''Women, Concern for [[Special:MyLanguage/Urethritis\|Urethritis]]'''
	*[[Ceftriaxone]] 250mg IM x1 AND [[azithromycin]] 1gm PO x1 AND [[nitrofurantoin]] ER 100mg BID x5d, OR		*[[Special:MyLanguage/Ceftriaxone\|Ceftriaxone]] 250mg IM x1 AND [[Special:MyLanguage/azithromycin\|azithromycin]] 1gm PO x1 AND [[Special:MyLanguage/nitrofurantoin\|nitrofurantoin]] ER 100mg BID x5d, OR
	*[[Levofloxacin]] 500mg QD x 14d (covers urinary pathogens, [[GC]], and [[chlamydia]])		*[[Special:MyLanguage/Levofloxacin\|Levofloxacin]] 500mg QD x 14d (covers urinary pathogens, [[Special:MyLanguage/GC\|GC]], and [[Special:MyLanguage/chlamydia\|chlamydia]])
	**[[GC]] resistance to fluoroquinolones is increasing		**[[Special:MyLanguage/GC\|GC]] resistance to fluoroquinolones is increasing

	'''Men'''		'''Men'''
	*[[Ciprofloxacin]] 500mg BID x10-14d, OR		*[[Special:MyLanguage/Ciprofloxacin\|Ciprofloxacin]] 500mg BID x10-14d, OR
	*[[Cefpodoxime]] 200 mg BID x10-14d		*[[Special:MyLanguage/Cefpodoxime\|Cefpodoxime]] 200 mg BID x10-14d


	===Inpatient Options===		===Inpatient Options===
	*[[Ciprofloxacin]] 400mg IV q12hr, OR
	*[[Ceftriaxone]] 1gm IV QD, OR		*[[Special:MyLanguage/Ciprofloxacin\|Ciprofloxacin]] 400mg IV q12hr, OR
	*[[Cefotaxime]] 1-2gm IV q8hr, OR		*[[Special:MyLanguage/Ceftriaxone\|Ceftriaxone]] 1gm IV QD, OR
	*[[Gentamicin]] 3mg/kg/day divided q8hr +/- ampicillin 1–2 gm q4hr, OR		*[[Special:MyLanguage/Cefotaxime\|Cefotaxime]] 1-2gm IV q8hr, OR
	*[[Piperacillin/Tazobactam]] 3.375 gm IV q6hr, OR		*[[Special:MyLanguage/Gentamicin\|Gentamicin]] 3mg/kg/day divided q8hr +/- ampicillin 1–2 gm q4hr, OR
	*[[Cefepime]] 2gm IV q8hr, OR		*[[Special:MyLanguage/Piperacillin/Tazobactam\|Piperacillin/Tazobactam]] 3.375 gm IV q6hr, OR
	*[[Imipenem]] 500mg IV q8hr		*[[Special:MyLanguage/Cefepime\|Cefepime]] 2gm IV q8hr, OR
			*[[Special:MyLanguage/Imipenem\|Imipenem]] 500mg IV q8hr
			</translate>

Shidoe daPA: /* Outpatient */

2025-08-28T15:42:12Z

Outpatient

← Older revision		Revision as of 15:42, 28 August 2025
Line 2:		Line 2:
	'''Women, Uncomplicated'''		'''Women, Uncomplicated'''
	*[[Nitrofurantoin]] ER 100mg BID x 5d, OR		*[[Nitrofurantoin]] ER 100mg BID x 5d, OR
	*[[TMP/SMX]] DS (160/800mg) 1 tab BID x 3d, OR		*[[TMP/SMX]] DS (160/800mg) 1 tab BID x 3d (Females) x7days (Males), OR
	*[[Cephalexin]] 250mg QID x 5d, OR		*[[Cephalexin]] 250mg QID x 5d, OR
	*[[Ciprofloxacin]] 250mg BID x3d		*[[Ciprofloxacin]] 250mg BID x3d

ClaireLewis at 17:01, 15 October 2019

2019-10-15T17:01:47Z

← Older revision		Revision as of 17:01, 15 October 2019
Line 25:		Line 25:
	*[[Ciprofloxacin]] 400mg IV q12hr, OR		*[[Ciprofloxacin]] 400mg IV q12hr, OR
	*[[Ceftriaxone]] 1gm IV QD, OR		*[[Ceftriaxone]] 1gm IV QD, OR
	*Cefotaxime 1-2gm IV q8hr, OR		*[[Cefotaxime]] 1-2gm IV q8hr, OR
	*[[Gentamicin]] 3mg/kg/day divided q8hr +/- ampicillin 1–2 gm q4hr, OR		*[[Gentamicin]] 3mg/kg/day divided q8hr +/- ampicillin 1–2 gm q4hr, OR
	*[[Piperacillin/Tazobactam]] 3.375 gm IV q6hr, OR		*[[Piperacillin/Tazobactam]] 3.375 gm IV q6hr, OR
	*[[Cefepime]] 2gm IV q8hr, OR		*[[Cefepime]] 2gm IV q8hr, OR
	*[[Imipenem]] 500mg IV q8hr		*[[Imipenem]] 500mg IV q8hr

Mrosen5506: /* Outpatient */

2018-08-11T19:53:01Z

Outpatient

← Older revision		Revision as of 19:53, 11 August 2018
Line 6:		Line 6:
	*[[Ciprofloxacin]] 250mg BID x3d		*[[Ciprofloxacin]] 250mg BID x3d
	**Avoid using fluoroquinolone for the first-line treatment of uncomplicated urinary tract infections (UTIs) in women.<ref>Choosing Wisely. American Urogynecologic Society. http://www.choosingwisely.org/societies/american-urogynecologic-society</ref>		**Avoid using fluoroquinolone for the first-line treatment of uncomplicated urinary tract infections (UTIs) in women.<ref>Choosing Wisely. American Urogynecologic Society. http://www.choosingwisely.org/societies/american-urogynecologic-society</ref>
			*[[Fosfomycin]] 3 g PO once
			**Lower clinical and microbiologic success compared to nitrofurantoin TID for 5 days <ref>Huttner, A., Kowalczyk, A., Turjeman, A., Babich, T., Brossier, C., Eliakim-Raz, N., … Harbarth, S. (2018). Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial. JAMA: The Journal of the American Medical Association, 319(17), 1781–1789.</ref>

	'''Women, Complicated'''		'''Women, Complicated'''

← Older revision		Revision as of 12:58, 20 March 2026
Line 30:		Line 30:
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Imipenem/Cilastatin\|dose=500mg IV q8hr\|context=Inpatient}}		*{{AntibioticDose\|disease=Acute cystitis\|drug=Imipenem/Cilastatin\|dose=500mg IV q8hr\|context=Inpatient}}
	*{{AntibioticDose\|drug=Cefotetan\|dose=500 mg IM/IV q12h\|context=UTI, uncomplicated\|disease=Acute cystitis\|population=Adult}}		*{{AntibioticDose\|drug=Cefotetan\|dose=500 mg IM/IV q12h\|context=UTI, uncomplicated\|disease=Acute cystitis\|population=Adult}}

			===Pediatric===
			*{{AntibioticDose\|disease=Acute cystitis\|drug=Trimethoprim-Sulfamethoxazole DS\|display=TMP/SMX\|dose=6-12mg/kg/day (TMP) PO divided BID x 7-10 days\|context=Pediatric\|population=Pediatric}}
			*{{AntibioticDose\|disease=Acute cystitis\|drug=Cephalexin\|dose=25-50mg/kg/day PO divided q6-8h x 7-10 days (max 500mg/dose)\|context=Pediatric\|population=Pediatric}}
			*{{AntibioticDose\|disease=Acute cystitis\|drug=Nitrofurantoin\|dose=5-7mg/kg/day PO divided q6h x 7-10 days; avoid in infants <1 month\|context=Pediatric\|population=Pediatric}}
			*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefpodoxime\|dose=10mg/kg/day PO divided BID (max 200mg/dose)\|context=Pediatric\|population=Pediatric}}
			*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefixime\|dose=8mg/kg/day PO daily (max 400mg)\|context=Pediatric\|population=Pediatric}}

			====Pediatric Inpatient====
			*{{AntibioticDose\|disease=Acute cystitis\|drug=Ceftriaxone\|dose=50-75mg/kg IV daily (max 2g)\|context=Pediatric Inpatient\|population=Pediatric}}
			*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefotaxime\|dose=50mg/kg IV q8hrs (max 2g/dose)\|context=Pediatric Inpatient\|population=Pediatric}}
			*{{AntibioticDose\|disease=Acute cystitis\|drug=Gentamicin\|dose=2.5mg/kg IV q8hrs\|context=Pediatric Inpatient\|population=Pediatric}} +/- [[Ampicillin]] 50mg/kg IV q6hrs

← Older revision		Revision as of 10:51, 20 March 2026
Line 29:		Line 29:
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefepime\|dose=2gm IV q8hr\|context=Inpatient}}, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefepime\|dose=2gm IV q8hr\|context=Inpatient}}, OR
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Imipenem/Cilastatin\|dose=500mg IV q8hr\|context=Inpatient}}		*{{AntibioticDose\|disease=Acute cystitis\|drug=Imipenem/Cilastatin\|dose=500mg IV q8hr\|context=Inpatient}}
			*{{AntibioticDose\|drug=Cefotetan\|dose=500 mg IM/IV q12h\|context=UTI, uncomplicated\|disease=Acute cystitis\|population=Adult}}

← Older revision		Revision as of 02:53, 20 March 2026
Line 1:		Line 1:
	~~<noinclude><languages/></noinclude>~~		===Outpatient=== '''Women, Uncomplicated'''
	~~<translate>~~

	===Outpatient=== ~~<!--T:1-->~~

	~~<!--T:2-->~~
	'''Women, Uncomplicated'''
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Nitrofurantoin\|dose=ER 100mg BID x 5d\|context=Outpatient, Women Uncomplicated}}, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Nitrofurantoin\|dose=ER 100mg BID x 5d\|context=Outpatient, Women Uncomplicated}}, OR
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Trimethoprim-Sulfamethoxazole DS\|display=TMP/SMX\|dose=DS (160/800mg) 1 tab BID x 3d (Females) x7days (Males)\|context=Outpatient, Women Uncomplicated}}, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Trimethoprim-Sulfamethoxazole DS\|display=TMP/SMX\|dose=DS (160/800mg) 1 tab BID x 3d (Females) x7days (Males)\|context=Outpatient, Women Uncomplicated}}, OR
Line 18:		Line 12:
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefpodoxime\|dose=200 mg BID x10-14d\|context=Outpatient, Women Complicated}}		*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefpodoxime\|dose=200 mg BID x10-14d\|context=Outpatient, Women Complicated}}

	~~<!--T:3-->~~		'''Women, Concern for [[Urethritis\|Urethritis]]'''
	'''Women, Concern for [[~~Special:MyLanguage/~~Urethritis\|Urethritis]]'''
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Ceftriaxone\|dose=250mg IM x1\|context=Urethritis Concern}} AND [[azithromycin]] 1gm PO x1 AND [[nitrofurantoin]] ER 100mg BID x5d, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Ceftriaxone\|dose=250mg IM x1\|context=Urethritis Concern}} AND [[azithromycin]] 1gm PO x1 AND [[nitrofurantoin]] ER 100mg BID x5d, OR
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Levofloxacin\|dose=500mg QD x 14d\|context=Urethritis Concern}} (covers urinary pathogens, [[~~Special:MyLanguage/~~GC\|GC]], and [[~~Special:MyLanguage/~~chlamydia\|chlamydia]])		*{{AntibioticDose\|disease=Acute cystitis\|drug=Levofloxacin\|dose=500mg QD x 14d\|context=Urethritis Concern}} (covers urinary pathogens, [[GC\|GC]], and [[chlamydia\|chlamydia]])
	**[[~~Special:MyLanguage/~~GC\|GC]] resistance to fluoroquinolones is increasing		**[[GC\|GC]] resistance to fluoroquinolones is increasing

	~~<!--T:4-->~~
	'''Men'''		'''Men'''
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Ciprofloxacin\|dose=500mg BID x10-14d\|context=Men}}, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Ciprofloxacin\|dose=500mg BID x10-14d\|context=Men}}, OR
Line 30:		Line 22:


	===Inpatient Options=== ~~<!--T:5-->~~		===Inpatient Options=== *{{AntibioticDose\|disease=Acute cystitis\|drug=Ciprofloxacin\|dose=400mg IV q12hr\|context=Inpatient}}, OR

	~~<!--T:6-->~~
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Ciprofloxacin\|dose=400mg IV q12hr\|context=Inpatient}}, OR
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Ceftriaxone\|dose=1gm IV QD\|context=Inpatient}}, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Ceftriaxone\|dose=1gm IV QD\|context=Inpatient}}, OR
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefotaxime\|dose=1-2gm IV q8hr\|context=Inpatient}}, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefotaxime\|dose=1-2gm IV q8hr\|context=Inpatient}}, OR
Line 40:		Line 29:
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefepime\|dose=2gm IV q8hr\|context=Inpatient}}, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefepime\|dose=2gm IV q8hr\|context=Inpatient}}, OR
	*{{AntibioticDose\|disease=Acute cystitis\|drug=Imipenem/Cilastatin\|dose=500mg IV q8hr\|context=Inpatient}}		*{{AntibioticDose\|disease=Acute cystitis\|drug=Imipenem/Cilastatin\|dose=500mg IV q8hr\|context=Inpatient}}
	~~</translate>~~

← Older revision		Revision as of 23:38, 19 March 2026
Line 6:		Line 6:
	<!--T:2-->		<!--T:2-->
	'''Women, Uncomplicated'''		'''Women, Uncomplicated'''
	*~~[[Special:MyLanguage/~~Nitrofurantoin\|~~Nitrofurantoin]]~~ ER 100mg BID x 5d, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Nitrofurantoin\|dose=ER 100mg BID x 5d\|context=Outpatient, Women Uncomplicated}}, OR
	*~~[[Special:MyLanguage/~~TMP/SMX\|~~TMP/SMX]]~~ DS (160/800mg) 1 tab BID x 3d (Females) x7days (Males), OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Trimethoprim-Sulfamethoxazole DS\|display=TMP/SMX\|dose=DS (160/800mg) 1 tab BID x 3d (Females) x7days (Males)\|context=Outpatient, Women Uncomplicated}}, OR
	*~~[[Special:MyLanguage/~~Cephalexin\|~~Cephalexin]]~~ 250mg QID x 5d, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Cephalexin\|dose=250mg QID x 5d\|context=Outpatient, Women Uncomplicated}}, OR
	*~~[[Special:MyLanguage/~~Ciprofloxacin\|~~Ciprofloxacin]]~~ 250mg BID x3d		*{{AntibioticDose\|disease=Acute cystitis\|drug=Ciprofloxacin\|dose=250mg BID x3d\|context=Outpatient, Women Uncomplicated}}
	**Avoid using fluoroquinolone for the first-line treatment of uncomplicated urinary tract infections (UTIs) in women.<ref>Choosing Wisely. American Urogynecologic Society. http://www.choosingwisely.org/societies/american-urogynecologic-society</ref>		**Avoid using fluoroquinolone for the first-line treatment of uncomplicated urinary tract infections (UTIs) in women.<ref>Choosing Wisely. American Urogynecologic Society. http://www.choosingwisely.org/societies/american-urogynecologic-society</ref>
	*~~[[Special:MyLanguage/~~Fosfomycin\|~~Fosfomycin]]~~ 3 g PO once		*{{AntibioticDose\|disease=Acute cystitis\|drug=Fosfomycin\|dose=3 g PO once\|context=Outpatient, Women Uncomplicated}}
	**Lower clinical and microbiologic success compared to nitrofurantoin TID for 5 days <ref>Huttner, A., Kowalczyk, A., Turjeman, A., Babich, T., Brossier, C., Eliakim-Raz, N., … Harbarth, S. (2018). Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial. JAMA: The Journal of the American Medical Association, 319(17), 1781–1789.</ref>		**Lower clinical and microbiologic success compared to nitrofurantoin TID for 5 days <ref>Huttner, A., Kowalczyk, A., Turjeman, A., Babich, T., Brossier, C., Eliakim-Raz, N., … Harbarth, S. (2018). Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial. JAMA: The Journal of the American Medical Association, 319(17), 1781–1789.</ref>

	'''Women, Complicated'''		'''Women, Complicated'''
	*~~[[Special:MyLanguage/~~Ciprofloxacin\|~~Ciprofloxacin]]~~ 500mg BID x10-14d, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Ciprofloxacin\|dose=500mg BID x10-14d\|context=Outpatient, Women Complicated}}, OR
	*~~[[Special:MyLanguage/~~Cefpodoxime\|~~Cefpodoxime]]~~ 200 mg BID x10-14d		*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefpodoxime\|dose=200 mg BID x10-14d\|context=Outpatient, Women Complicated}}

	<!--T:3-->		<!--T:3-->
	'''Women, Concern for [[Special:MyLanguage/Urethritis\|Urethritis]]'''		'''Women, Concern for [[Special:MyLanguage/Urethritis\|Urethritis]]'''
	*~~[[Special:MyLanguage/~~Ceftriaxone\|~~Ceftriaxone]]~~ 250mg IM x1 AND [[~~Special:MyLanguage/azithromycin\|~~azithromycin]] 1gm PO x1 AND [[~~Special:MyLanguage/nitrofurantoin\|~~nitrofurantoin]] ER 100mg BID x5d, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Ceftriaxone\|dose=250mg IM x1\|context=Urethritis Concern}} AND [[azithromycin]] 1gm PO x1 AND [[nitrofurantoin]] ER 100mg BID x5d, OR
	*~~[[Special:MyLanguage/~~Levofloxacin\|~~Levofloxacin]]~~ 500mg QD x 14d (covers urinary pathogens, [[Special:MyLanguage/GC\|GC]], and [[Special:MyLanguage/chlamydia\|chlamydia]])		*{{AntibioticDose\|disease=Acute cystitis\|drug=Levofloxacin\|dose=500mg QD x 14d\|context=Urethritis Concern}} (covers urinary pathogens, [[Special:MyLanguage/GC\|GC]], and [[Special:MyLanguage/chlamydia\|chlamydia]])
	**[[Special:MyLanguage/GC\|GC]] resistance to fluoroquinolones is increasing		**[[Special:MyLanguage/GC\|GC]] resistance to fluoroquinolones is increasing

	<!--T:4-->		<!--T:4-->
	'''Men'''		'''Men'''
	*~~[[Special:MyLanguage/~~Ciprofloxacin\|~~Ciprofloxacin]]~~ 500mg BID x10-14d, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Ciprofloxacin\|dose=500mg BID x10-14d\|context=Men}}, OR
	*~~[[Special:MyLanguage/~~Cefpodoxime\|~~Cefpodoxime]]~~ 200 mg BID x10-14d		*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefpodoxime\|dose=200 mg BID x10-14d\|context=Men}}


Line 33:		Line 33:

	<!--T:6-->		<!--T:6-->
	*~~[[Special:MyLanguage/~~Ciprofloxacin\|~~Ciprofloxacin]]~~ 400mg IV q12hr, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Ciprofloxacin\|dose=400mg IV q12hr\|context=Inpatient}}, OR
	*~~[[Special:MyLanguage/~~Ceftriaxone\|~~Ceftriaxone]]~~ 1gm IV QD, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Ceftriaxone\|dose=1gm IV QD\|context=Inpatient}}, OR
	*~~[[Special:MyLanguage/~~Cefotaxime\|~~Cefotaxime]]~~ 1-2gm IV q8hr, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefotaxime\|dose=1-2gm IV q8hr\|context=Inpatient}}, OR
	*~~[[Special:MyLanguage/~~Gentamicin\|~~Gentamicin]]~~ 3mg/kg/day divided q8hr +/- ampicillin 1–2 gm q4hr, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Gentamicin\|dose=3mg/kg/day divided q8hr\|context=Inpatient}} +/- ampicillin 1–2 gm q4hr, OR
	*~~[[Special:MyLanguage/~~Piperacillin/Tazobactam\|~~Piperacillin/Tazobactam]]~~ 3.375 gm IV q6hr, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Piperacillin/Tazobactam\|dose=3.375 gm IV q6hr\|context=Inpatient}}, OR
	*~~[[Special:MyLanguage/~~Cefepime\|~~Cefepime]]~~ 2gm IV q8hr, OR		*{{AntibioticDose\|disease=Acute cystitis\|drug=Cefepime\|dose=2gm IV q8hr\|context=Inpatient}}, OR
	*~~[[Special:MyLanguage~~/~~Imipenem~~\|~~Imipenem]]~~ 500mg IV q8hr		*{{AntibioticDose\|disease=Acute cystitis\|drug=Imipenem/Cilastatin\|dose=500mg IV q8hr\|context=Inpatient}}
	</translate>		</translate>